衰弱老年人房颤与口服抗凝:英国全国初级保健电子病历队列研究
该研究基于英格兰384家全科诊所的536,955名≥65岁患者电子健康记录,随访15.4个月,按电子衰弱指数(eFI)分层分析房颤患病、口服抗凝(OAC)处方及死亡、出血、跌倒、卒中风险。结果显示房颤患病率与卒中风险随衰弱程度增加而升高,但符合OAC条件者处方率仅约50%,衰弱与死亡、消化道出血、跌倒及女性卒中风险升高相关。
要点
- 房颤患病率随eFI分层升高:fit 2.9%、mild 11.2%、moderate 22.2%、severe 31.5%。
- CHA2DS2-Vasc≥2的房颤患者OAC处方率:fit 41.7%、mild 53.2%、moderate 55.6%、severe 53.4%。
- 重度衰弱较fit者死亡HR 4.09(95%CI 3.43-4.89)、跌倒HR 8.03(4.60-14.03)。
核心结论
- 在英格兰≥65岁人群中,房颤与卒中风险随衰弱程度增加而升高,但符合OAC条件者的OAC处方率仅约50%。
- 鉴于死亡、疾病负担与卒中预防之间存在竞争性需求,该人群需要更分层的卒中预防策略。
研究设计与样本
- 基于英格兰ResearchOne电子健康记录数据库的队列研究,纳入384家全科诊所536,955名≥65岁患者,观察期15.4个月,末次随访2017年4月11日。
- 按电子衰弱指数(eFI)分为fit、mild、moderate、severe四类,分析CHA2DS2-Vasc≥2的房颤患者OAC处方及调整后全因死亡、脑血管病、出血和跌倒风险。
主要发现
- 房颤患病率与房颤患者平均CHA2DS2-Vasc随eFI类别升高而增加:fit 2.9%、2.2;mild 11.2%、3.2;moderate 22.2%、4.0;severe 31.5%、5.0。
- CHA2DS2-Vasc≥2的房颤患者中,OAC处方率mild 53.2%、moderate 55.6%、severe 53.4%,均高于fit的41.7%。
- 符合OAC条件的房颤患者中,重度衰弱较fit者全因死亡HR 4.09(95%CI 3.43-4.89)、消化道出血HR 2.17(1.45-3.25)、跌倒HR 8.03(4.60-14.03)。
- 女性中,重度衰弱较fit者卒中HR 3.63(95%CI 1.10-12.02)。
关键数值与推荐
- 房颤伴CHA2DS2-Vasc≥2为评估OAC处方的条件;OAC处方率在各eFI类别中约为41.7%至55.6%。
- 衰弱分层采用eFI四类:fit、mild、moderate、severe。
临床怎么用
- 对老年房颤患者应评估衰弱程度,并将其纳入卒中预防与抗凝决策的分层考量。
- 衰弱越重死亡、出血、跌倒风险越高,抗凝获益与风险需个体化权衡,不宜仅因衰弱而简单停用或统一处方OAC。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial fibrillation (AF) is common in older people and is associated with increased stroke risk that may be reduced by oral anticoagulation (OAC). Frailty also increases with increasing age, yet the extent of OAC prescription in older people according to extent of frailty in people with AF is insufficiently described. METHODS: An electronic health records study of 536,955 patients aged ≥65 years from ResearchOne in England (384 General Practices), over 15.4 months, last follow-up 11th April 2017. OAC prescription for AF with CHA2DS2-Vasc ≥2, adjusted (demographic and treatments) risk of all-cause mortality, and subsequent cerebrovascular disease, bleeding and falls were estimated by electronic frailty index (eFI) category of fit, mild, moderate and severe frailty. RESULTS: AF prevalence and mean CHA2DS2-Vasc for those with AF increased with increasing eFI category (fit 2.9%, 2.2; mild 11.2%, 3.2; moderate 22.2%, 4.0; and severe 31.5%, 5.0). For AF with CHA2DS2-Vasc ≥2, OAC prescription was higher for mild (53.2%), moderate (55.6%) and severe (53.4%) eFI categories than fit (41.7%). In those with AF and eligible for OAC, frailty was associated with increased risk of death (HR for severe frailty compared with fit 4.09, 95% confidence interval 3.43-4.89), gastrointestinal bleeding (2.17, 1.45-3.25), falls (8.03, 4.60-14.03) and, among women, stroke (3.63, 1.10-12.02). CONCLUSION: Among older people in England, AF and stroke risk increased with increasing degree of frailty; however, OAC prescription approximated 50%. Given competing demands of mortality, morbidity and stroke prevention, greater attention to stratified stroke prevention is needed for this group of the population.
引用
- Wilkinson C, Clegg A, Todd O, et al. Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study. Age Ageing. 2021. PMID: 33951158. doi:10.1093/ageing/afaa265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。